NEW YORK, Feb. 16, 2017 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against The Southern Company (“Southern Company” or the “Company”) (NYSE:SO) and certain of its officers, on behalf of shareholders who purchased Southern Company securities between April 25, 2012 and October 29, 2013, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/soc.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and failed to disclose adverse information about the progress of the Kemper Plant, reassuring investors that the project would be completed by the critical May 2014 deadline, even after cost overruns and other delays began to materialize. Once the true details were made known to the investing public, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/soc or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Southern Company you have until March 24, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
FDA Approves Mitapivat for Anemia in Thalassemia Patients
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy 



